Clinical Trial Update: Study on Two Different Formulations of 6-mercaptopurine. Tablet Versus Oral Liquid [Phase 4]

View source ↗

Summary

A Phase 4 trial is comparing two formulations of 6-mercaptopurine (tablet versus oral liquid) for acute lymphoblastic leukemia; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• 6-mercaptopurine (6-mercaptopurine)

Snippet

Sponsor: Kjeld Schmiegelow | Conditions: Acute Lymphoblastic Leukemia, 6-mercaptopurine Therapy | Phase 4 | Status: UNKNOWN